| ¿µ¹® | bipolar disorder | ÇÑ±Û | ¾ç±Ø¼º Àå¾Ö |
|---|---|---|---|
| ¼³¸í | ¿ÜºÎÀڱؿ¡ ÀÇÇØ¼ º¯ÈÇÏÁö ¾Ê´Â Áö¼ÓÀûÀÎ ¸¶À½ÀÇ »óÅÂÀÎ ±âºÐ(mood)¿¡ ÀÌ»óÀÌ ÀÖ´Â Á¤µ¿Àå¾ÖÀÇ ÇÑ Á¾·ù. Á¤µ¿Àå¾ÖÀÇ ´ëÇ¥ÀûÀÎ ÁúȯÀ¸·Î´Â ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ ±âºÐÀÌ ¿ì¿ïÇÑ ¿ì¿ïÁõ(depression)°ú Áö¼ÓÀûÀ¸·Î ¿ÜºÎÀÇ Àڱؿ¡ °ü°è¾øÀÌ Áö¼ÓÀûÀ¸·Î ±âºÐÀÌ µé¶ß´Â Á¶Áõ(mania)ÀÌ ÀÖ´Ù. ¿ì¿ïÁõ°ú Á¶ÁõÀÌ ÁÖ±âÀûÀ¸·Î ¹Ýº¹ÀÌ µÇ´Â Á¤½ÅÁúȯ°ú Á¶Áõ¸¸ ÀÖ°í ¿ì¿ïÁõÀº ¾ø´Â °æ¿ì¸¦ ¸ðµÎ Æ÷ÇÔÇÏ´Â °³³äÀÌ´Ù. |
||
| ¿µ¹® | language disorder | ÇÑ±Û | ¾ð¾îÀå¾Ö |
|---|---|---|---|
| ¼³¸í | ¸»À» ¹Ù¸£°Ô ¹ßÀ½ÇÏÁö ¸øÇϰųª Á¤È®ÇÏ°Ô ÀÌÇØÇÏÁö ¸øÇÏ´Â º´Áõ. ±³Åë¼ö´ÜÀ¸·Î¼ÀÇ ¾ð¾î·Î Á¤º¸¸¦ Àü´ÞÇϴµ¥ ÀÖ¾î¼ÀÇ Àå¾ÖÀÌ´Ù. ¾ð¾î¸¦ ÀÌÇØ, Ç¥ÃâÇÏ´Â »ý¸®ÇÐÀû, ½É¸®ÇÐÀû, ¾ð¾îÇÐÀû, ¹°¸®ÇÐÀû, »çȸÇÐÀûÀÎ °¢ °úÁ¤¿¡¼ÀÇ Áúº´À̳ª Àå¾Ö·Î ÀÎÇØ ÀϾ¸ç ±× ¿øÀÎÀ̳ª º´Å¿¡ µû¶ó ±¸À½Àå¾Ö, ¸»´õµë, À½¼ºÀå¾Ö, ¾ð¾î¹ß´ÞÁöü, û·ÂÀå¾Ö, ¼±Ãµ±âÇü µî ¸¹Àº Áúº´, Àå¾Ö·Î ¼¼ºÐµÈ´Ù. ¿øÀÎ ¹× º´ÅÂÀÇ °Ë»ç, Áø´Ü¿¡´Â ³»°ú, À̺ñÀÎÈİú, Á¤½Å°ú, Ä¡°ú µî ¿©·¯ °ú¸ñ¿¡ °ÉÃÄ Á¤¹ÐÁ¶»ç¸¦ ÇÔ°ú µ¿½Ã¿¡ ¾ð¾î±â´É°Ë»ç¸¦ ÇØ¾ß ÇÑ´Ù. |
||
| ¿µ¹® | personality disorder | ÇÑ±Û | ÀΰÝÀå¾Ö, ¼º°ÝÀå¾Ö |
|---|---|---|---|
| ¼³¸í | Ÿ°í³ Àμº°ú ¼ºÀå°úÁ¤ÀÇ ¿©·¯ »ç°Ç, ±×¸®°í ±³À°Á¤µµ¿¡ µû¶ó °³ÀÎÀÇ ÀΰÝÀº Çü¼ºµÈ´Ù. ÀÌ·± ÀΰÝ(¼º°Ý)ÀÌ »çȸ»ýȰ, ȤÀº °¡Á·»ýȰ¿¡ ÁöÀåÀ» Áְųª, ÀÚ±âÀÚ½ÅÀÇ »ýȰ¿¡ ÇÇÇØ¸¦ ÁÖ´Â °æ¿ì, À̸¦ ÀΰÝÀå¾Ö¶ó ºÎ¸¥´Ù. ½ÇÁ¦·Î ÀÌ·± ÀÏ·ÃÀÇ ¼º°ÝµéÀº ´©±¸³ª Á¤»óÀûÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖÀ¸³ª, À̻󼺰ÝÀÌ ½ÉÇÑ °æ¿ì Ä¡·áÀÇ ´ë»óÀÌ µÈ´Ù. |
||
| ¿µ¹® | narcissistic personality disorder | ÇÑ±Û | ÀÚ±â¾ÖÀû ÀΰÝÀå¾Ö |
|---|---|---|---|
| ¼³¸í | ÀÚ½ÅÀÇ Á߿伺°ú µ¶Æ¯ÇÔ, À¯ÀÏÇÔ¿¡ ´ëÇÑ ±¤ÀûÀÎ ÁýÂø°ú ÀÚ½ÅÀÌ ¼º°øÇÒ °ÍÀ̶ó´Â Áö³ªÄ£ ÁýÂøÀ» º¸¿©ÁÖ´Â ¼º°ÝÀå¾Ö. Áö³ªÄ£ Àڱ⿡ÀÇ ¸¸Á·°¨À» °¡Áö°í, Áö³ªÄ£ Àڽۨ, ¼º°ø¿¡ ´ëÇÑ È®½ÅÀ» Áö´Ï°í ÀÖ´Ù. |
||
| ¿µ¹® | conversion disorder | ÇÑ±Û | ÀüȯÀå¾Ö |
|---|---|---|---|
| ¼³¸í | ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» ƯÁ¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °ÍÀ» ¸» ÇÑ´Ù. ÀÌ ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ» ÁÖ·Î ³ªÅ¸³»´Â Á¤½ÅÁúȯÀ» ÀüȯÀå¾Ö¶ó°í ÇÑ´Ù. ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ¸·Î ´ëÇ¥ÀûÀÎ °ÍÀ¸·Î´Â ¸¶ºñ, °æ·Ã, ÀǽÄÀå¾Ö µîÀÌ´Ù. ´ë°³ ±× º´À» ÀÏÀ¸Å³ ¸¸ÇÑ º´º¯ÀÌ Á¸ÀçÇÏÁö ¾Ê°í, ½É¸®Àû °¥µîÀÌ ½ÉÇÒ °æ¿ì¿¡ ´õ¿í Áõ»óÀÌ ½ÉÇØÁö°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇØ¼ ³»ºÎÀû °¥µîÀÌ °¨¼ÒµÇ°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇÑ 2Â÷Àû À̵æ(°¡Á·µéÀÇ °ü½ÉÁýÁß, µ¹ºÁÁÜ)ÀÌ ÀÖ´Â °ÍÀÌ ÀÌ ÀüȯÀå¾ÖÀÇ Æ¯Â¡ÀÌ´Ù. ´ë°³ ÀÌ ÀüȯÀå¾Ö ȯÀÚ´Â ÀÚ½ÅÀÇ Áúȯ¿¡ ´ëÇØ¼ Ư¡ÀûÀ¸·Î ¸Å¿ì ¹«°ü½ÉÇÑ Åµµ¸¦ ÃëÇÑ´Ù. |
||
| PAD | pain and distress; patient surface axis depth; percutaneous abscess drainage; percutaneous automated... |
|---|---|
| SPD | schizotypal personality disorder; sociopathic personality disorder; specific paroxysmal discharge; s... |
| ADME | [drug] absorption, distribution, metabolism, and excretion |
| BM | Bachelor of Medicine; barium meal; basal medium; basal metabolism; basement membrane; basilar membra... |
| CMI | carbohydrate metabolism index; care management integration; case mix index; cell-mediated immunity; ... |
| protein metabolism | Decomposition and synthesis of protein in the tissues. Synonym: proteometabolism. (05 Mar 2000) |
|---|---|
| xenobiotic metabolism | <biochemistry> This is the sum of the physical and chemical changes that affect foreign substances in living organisms from uptake to excretion. (09 Oct 1997) |
| high density lipoprotein | <biochemistry> These lipoproteins acts to carry cholesterol in the bloodstream. Raised high density lipoprotein levels have been correlated with a lower risk for heart disease. Less than 35 mg/dl is considered a positive risk factor for coronary artery disease, over 60 mg/dl is considered a negative risk factor (reduces your risk of heart disease). Recent studies show a low high density lipoprotein level is the strongest predictor of cardiovascular death in women. Acronym: HDL (18 Nov 1997) |
| secondary metabolism | Pathways producing specialised metabolic products that are not found inevery cell. (09 Oct 1997) |
| pyruvate metabolism, inborn errors | Hereditary disorders of pyruvate metabolism. They are difficult to diagnose and describe because pyruvate is a key intermediate in glycolysis, gluconeogenesis, and the tricarboxylic acid cycle. Some inherited metabolic disorders may alter pyruvate metabolism indirectly. Disorders in pyruvate metabolism appear to lead to deficiencies in neurotransmitter synthesis and, consequently, to nervous system disorders. (12 Dec 1998) |
| inborn error of metabolism | A genetic biochemical disorder of a specific enzyme that forms a metabolic block, e.g., phenylketonuria. (05 Mar 2000) |
| inborn errors of metabolism | Term coined by A. Garrod in 1908 applying to heritable disorders of biochemistry. Examples include albinism, cystinuria (a cause of kidney stones) and phenylketonuria (pku) are a few of the hundreds of inborn errors of metabolism. (12 Dec 1998) |
| intermediary metabolism | Enzyme-catalysed processeswithin cells that extract energy from nutrientmolecules and use that energy to construct cellular components. (09 Oct 1997) |
| intermediate density lipoprotein | Class of lipoproteins formed in degradation of very-low-density lipoproteins; about half are cleared quickly from the plasma into the liver by receptor-mediated endocytosis; the other half are degraded into low density lipoproteins. (05 Mar 2000) |
| iron metabolism disorders | Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. (12 Dec 1998) |
| oxidative metabolism | Respiration in the biochemical sense. (18 Nov 1997) |
| electrolyte metabolism | The chemical changes that various essential minerals (e.g., sodium, potassium, calcium, magnesium) undergo in the tissues. (05 Mar 2000) |
| energy metabolism | Those metabolic reactions whose role is to release or to provide energy. (05 Mar 2000) |
| familial high density lipoprotein deficiency | Familial high {density lipoprotein deficiency}; a heritable disorder of lipid metabolism characterised by almost complete absence from plasma of high density lipoproteins, and by storage of cholesterol esters in foam cells, tonsillar enlargement, an orange or yellow-gray colour of the pharyngeal and rectal mucosa, hepatosplenomegaly, lymph node enlargement, corneal opacity, and peripheral neuropathy; autosomal recessive inheritance. Synonym: familial high {density lipoprotein deficiency}, Tangier disease. Origin: G. An-, priv., + alpha, a, + lipoprotein + -aemia, blood (05 Mar 2000) |
| familial lipoprotein lipase deficiency | An rare inherited disorder where there is a deficiency of an enzyme (lipoprotein lipase) which breaks down fat molecules, causing the accumulation of fats or lipoproteins in the blood. Symptoms in infancy include abdominal pain (appears as if its colic), failure to thrive and skin lesions (xanthomas). (27 Sep 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|